InvestorsHub Logo
Followers 9
Posts 209
Boards Moderated 0
Alias Born 04/22/2014

Re: None

Tuesday, 06/23/2015 11:26:34 PM

Tuesday, June 23, 2015 11:26:34 PM

Post# of 4126
----------$$$$$$$$$ NEWS NEWS NEWS NEWS $$$$$$$$$$$$------------

Latest News Headlines for StemCells Inc

StemCells, Inc.'s Phase II Pathway Study For Cervical Spinal Cord Injury Approved By Health Canada *
Thursday 06/18/2015 08:05 AM ET - Dow Jones News
StemCells, Inc.'s Phase II Pathway Study for Cervical Spinal Cord Injury Approved by Health Canada
Thursday 06/18/2015 08:05 AM ET - GlobeNewsWire via Dow Jones News

StemCells, Inc.'s Phase II Pathway Study for Cervical Spinal Cord Injury Approved by Health Canada NEWARK, Calif., June 18, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of central nervous system diseases and disorders, announced today that Health Canada has authorized the Company to expand its Phase II clinical trial for chronic cervical spinal cord injury into Canada. The Pathway Study(TM) is designed to assess the efficacy of the Company's proprietary HuCNS-SC(R) platform technology (purified human neural stem cells) for the treatment of cervical spinal cord injury with the primary efficacy outcome being the change in motor strength of the various muscle groups in the upper extremities innervated by the cervical spinal cord.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent STEM News